14832 studies found for:    Studies With Results
Show Display Options
Rank Status Study
21 Completed
Has Results
Bioequivalence Study of the Fixed Dose Combination of 5 mg Saxagliptin and 500 mg Metformin XR Tablet (Manufactured in Mt Vernon, IN) Relative to 5 mg Saxagliptin Tablet and 500 mg Metformin XR Tablet (Manufactured in Evansville, IN)
Condition: Diabetes Mellitus
Interventions: Drug: saxagliptin;   Drug: metformin XR;   Drug: saxagliptin + metformin XR (FDC tablet)
22 Terminated
Has Results
Stem Cell Transplantation for Hematological Malignancies
Conditions: Leukemia, Lymphocytic, Acute;   AML;   MDS
Interventions: Procedure: Stem Cell Transplant;   Drug: Busulfan;   Drug: Cyclophosphamide;   Drug: Melphalan;   Drug: G-CSF;   Drug: ATG
23 Completed
Has Results
Lifestyle and Pregnancy: The Clinical Effect of Lifestyle Intervention During Pregnancy in Obese Women
Conditions: Maternal Obesity;   Gestational Weight Gain;   Obstetric Complications
Interventions: Other: Lifestyle intervention;   Other: Control;   Behavioral: Physical activity, dietetic counselling
24 Completed
Has Results
Automated Real-time Feedback on CPR Study
Condition: Heart Arrest
Intervention: Other: Laerdal Q-CPR /technology
25 Completed
Has Results
E.V.O.L.V.E. Trial™: EValuation Of Cinacalcet Hydrochloride (HCl) Therapy to Lower CardioVascular Events
Conditions: Secondary Hyperparathyroidism;   Chronic Kidney Disease
Interventions: Drug: Cinacalcet;   Drug: Placebo
26 Completed
Has Results
Induction Cetuximab (IM-C225), Gemcitabine, and Oxaliplatin in Pancreatic Cancer Patients
Condition: Pancreatic Cancer
Interventions: Drug: Cetuximab;   Drug: Gemcitabine;   Drug: Oxaliplatin;   Drug: Capecitabine;   Radiation: Radiotherapy
27 Completed
Has Results
Apremilast Safety and PK Study in Recalcitrant Plaque Psoriasis
Condition: Plaque-Type Psoriasis
Intervention: Drug: Apremilast
28 Completed
Has Results
Phase II Study of Alendronate Sodium in Children With High-Turnover Idiopathic Juvenile Osteoporosis
Condition: Osteoporosis
Intervention: Drug: Alendronate
29 Completed
Has Results
Divalproex Sodium Delayed-Release Tablets Under Fasting Conditions
Condition: Healthy
Interventions: Drug: divalproex sodium;   Drug: Depakote®
30 Terminated
Has Results
Renal Safety of Iopamidol Versus Iodixanol During Coronary Angiography in Diabetic Patients
Conditions: Chronic Renal Impairment;   Diabetes Mellitus
Interventions: Drug: Iopamidol injection 76%;   Drug: iodixanol
31 Completed
Has Results
S0220: Chemoradiotherapy Followed By Surgery and Docetaxel in Treating Patients With Pancoast Tumors
Condition: Lung Cancer
Interventions: Drug: cisplatin;   Drug: docetaxel;   Drug: etoposide;   Procedure: conventional surgery;   Radiation: radiation therapy
32 Completed
Has Results
A Clinical Trial of CSL's 2009 H1N1 Influenza Vaccine (CSL425) in Healthy Adults
Condition: Influenza Caused by the Novel Influenza A (H1N1) Virus
Intervention: Biological: CSL425
33 Completed
Has Results
The Utility of Nexium in Chronic Cough and Reflux Disease
Conditions: Cough;   GERD
Interventions: Drug: Esomeprazole;   Drug: Placebo
34 Completed
Has Results
Treatment Effect of Saxagliptin Compared With Placebo in Patients With Type 2 Diabetes and Renal Impairment
Condition: Type 2 Diabetes
Interventions: Drug: Saxagliptin;   Drug: Placebo
35 Completed
Has Results
REQUIP RLS Post Marketing Surveillance
Condition: Restless Legs Syndrome
Intervention: Drug: Ropinirole
36 Completed
Has Results
Albuterol Versus Xopenex in Treatment of Acute Asthma in the Emergency Department (ED)
Condition: Asthma
Intervention: Drug: xopenex
37 Completed
Has Results
VIT45 Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease
Condition: Anemia
Interventions: Drug: Ferrous Sulfate tablets;   Drug: Ferric Carboxymaltose (FCM)
38 Completed
Has Results
Trial to See if Topical Pennsaid for Knee Pain Affects Coagulation Values in Patients Who Are Also Taking Anticoagulants
Conditions: Osteoarthritis of the Knee;   Coagulopathy
Intervention: Drug: Pennsaid
39 Completed
Has Results
Paliperidone Extended Release in Schizophrenia Participants With Duration of Illness Less Than 10 Years
Condition: Schizophrenia
Intervention: Drug: Paliperidone ER
40 Completed
Has Results
Mobile Communication Technology for Adolescents With Diabetes
Condition: Type 1 Diabetes
Interventions: Device: GlucoPak;   Device: Cell Phone

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years